Keywords
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Obstetrics and Gynaecology CanadaREFERENCES
- 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum.Thyroid. 2017; 27: 315-389
- Subclinical hypothyroidism in the infertile female population: a guideline.Fertil Steril. 2015; 104: 545-553
- Treatment of subclinical hypothyroidism or hypothyroxinemia in pregnancy.N Engl J Med. 2017; 376: 815-825
- Effect of levothyroxine on miscarriage among women with normal thyroid function and thyroid autoimmunity undergoing in vitro fertilization and embryo transfer: a randomized clinical trial.JAMA. 2017; 318: 2190-2198
- Levothyroxine in women with thyroid peroxidase antibodies before conception.N Engl J Med. 2019; 380: 1316-1325
- Impact of levothyroxine therapy on obstetric, neonatal and childhood outcomes in women with subclinical hypothyroidism diagnosed in pregnancy: a systematic review and meta-analysis of randomised controlled trials.BMJ Open. 2018; 8e022837
- Antenatal thyroid screening and childhood cognitive function.N Engl J Med. 2012; 366: 493-501
- Variation in thyroid function in subclinical hypothyroidism: importance of clinical follow-up and therapy.Eur J Endocrinol. 2011; 164: 317-323
- Thyroid dysfunction and autoimmunity in infertile women.Thyroid. 2002; 12: 997-1001
- Prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome.Arch Gynecol Obstet. 2012; 285: 853-856
- Female infertility related to thyroid autoimmunity: the ovarian follicle hypothesis.Am J Reprod Immunol. 2011; 66: 108-114
- Elevated antithyroid peroxidase antibodies indicating Hashimoto's thyroiditis are associated with the treatment response in infertile women with polycystic ovary syndrome.Fertil Steril. 2010; 94: 2895-2897
- Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence.BMJ. 2011; 342: d2616
- Thyroid function test abnormalities during pregnancy.JAMA. 2019; 322: 617-619
- Association of thyroid function test abnormalities and thyroid autoimmunity with preterm birth: a systematic review and meta-analysis.JAMA. 2019; 322: 632-641
- The impact of thyroid function on intrauterine insemination outcome—a retrospective analysis.Reprod Biol Endocrinol. 2014; 12: 28
- Preconceptional thyroid-stimulating hormone levels and outcomes of intrauterine insemination among euthyroid infertile women.Fertil Steril. 2015; 103 (258–63 e1)
- Correlation of thyroid stimulating hormone (TSH) level with pregnancy outcome in women undergoing in vitro fertilization.Am J Obstet Gynecol. 2006; 194 (discussion 74–5): 1668-1674
- Thyroid function in infertile patients undergoing assisted reproduction.Am J Reprod Immunol. 2013; 70: 336-341
- Effect of levothyroxine treatment on in vitro fertilization and pregnancy outcome in infertile women with subclinical hypothyroidism undergoing in vitro fertilization/intracytoplasmic sperm injection.Fertil Steril. 2011; 95: 1650-1654
- Levothyroxine treatment in thyroid peroxidase antibody-positive women undergoing assisted reproduction technologies: a prospective study.Hum Reprod. 2005; 20: 1529-1533
- Preconception steroid treatment in infertile women with antithyroid autoimmunity undergoing ovarian stimulation and intrauterine insemination: a double-blind, randomized, prospective cohort study.Clin Ther. 2010; 32: 2415-2421
- In women with thyroid autoimmunity, does low-dose prednisolone administration, compared with no adjuvant therapy, improve in vitro fertilization clinical results?.J Obstet Gynaecol Res. 2015; 41: 722-728
- Potential significance of physiological and pharmacological glucocorticoids in early pregnancy.Hum Reprod Update. 2008; 14: 497-517
- The clinical use of corticosteroids in pregnancy.Hum Reprod Update. 2016; 22: 240-259
Article info
Publication history
Footnotes
This document reflects emerging clinical and scientific advances as of the publication date and is subject to change. The information is not meant to dictate an exclusive course of treatment or procedure. Institutions are free to amend the recommendations. The SOGC suggests, however, that they adequately document any such amendments.
Informed Consent: Everyone has the right and responsibility to make informed decisions about their care together with their health care providers. In order to facilitate this, the SOGC recommends that they provide their patients with information and support that is evidence-based, culturally appropriate, and personalized.
Language and Inclusivity: This document uses gendered language in order to facilitate plain language writing but is meant to be inclusive of all individuals, including those who do not identify as a woman/female. The SOGC recognizes and respects the rights of all people for whom the information in this document may apply, including but not limited to transgender, non-binary, and intersex people. The SOGC encourages health care providers to engage in respectful conversation with their patients about their gender identity and preferred gender pronouns and to apply these guidelines in a way that is sensitive to each person's needs.
Copyright: The contents of this document cannot be reproduced in any form, in whole or in part, without prior written permission of the publisher of the Journal of Obstetrics and Gynaecology Canada.
